ProPhase Labs, Inc.
PRPH
$0.3326
$0.00130.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.97M | -34.36M | -6.59M | -6.15M | -6.27M |
| Total Depreciation and Amortization | 1.60M | 694.00K | 2.51M | 1.73M | 1.72M |
| Total Amortization of Deferred Charges | 372.00K | 491.00K | 619.00K | 235.00K | 140.00K |
| Total Other Non-Cash Items | -7.05M | 11.35M | 660.00K | 771.00K | 24.00K |
| Change in Net Operating Assets | -2.27M | 18.27M | -1.23M | -1.40M | -754.00K |
| Cash from Operations | -3.38M | -3.55M | -4.03M | -4.82M | -5.14M |
| Capital Expenditure | -- | 163.00K | -176.00K | -26.00K | -867.00K |
| Sale of Property, Plant, and Equipment | 53.00K | 0.00 | 79.00K | 150.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 800.00K | -203.00K | 0.00 | 0.00 | 3.30M |
| Cash from Investing | 853.00K | -40.00K | -97.00K | 124.00K | 2.44M |
| Total Debt Issued | 204.00K | 1.53M | 4.47M | 1.41M | 2.46M |
| Total Debt Repaid | -1.51M | -1.75M | -1.61M | -709.00K | -185.00K |
| Issuance of Common Stock | 3.28M | 2.97M | 0.00 | 4.62M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -35.00K | 982.00K | -- | -- | -4.00K |
| Cash from Financing | 1.94M | 3.74M | 2.86M | 5.32M | 2.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -590.00K | 145.00K | -1.27M | 629.00K | -434.00K |